17 research outputs found
Mycobacterium tuberculosis causing tuberculous lymphadenitis in Maputo, Mozambique
BACKGROUND:
The zoonosis bovine tuberculosis (TB) is known to be responsible for a considerable proportion of extrapulmonary TB. In Mozambique, bovine TB is a recognised problem in cattle, but little has been done to evaluate how Mycobacterium bovis has contributed to human TB. We here explore the public health risk for bovine TB in Maputo, by characterizing the isolates from tuberculous lymphadenitis (TBLN) cases, a common manifestation of bovine TB in humans, in the Pathology Service of Maputo Central Hospital, in Mozambique, during one year.
RESULTS:
Among 110 patients suspected of having TBLN, 49 had a positive culture result. Of those, 48 (98 %) were positive for Mycobacterium tuberculosis complex and one for nontuberculous mycobacteria. Of the 45 isolates analysed by spoligotyping and Mycobacterial Interspersed Repetitive Unit - Variable Number Tandem Repeat (MIRU-VNTR), all were M. tuberculosis. No M. bovis was found. Cervical TBLN, corresponding to 39 (86.7 %) cases, was the main cause of TBLN and 66.7 % of those where from HIV positive patients. We found that TBLN in Maputo was caused by a variety of M. tuberculosis strains. The most prevalent lineage was the EAI (n?=?19; 43.2 %). Particular common spoligotypes were SIT 48 (EAI1_SOM sublineage), SIT 42 (LAM 9), SIT 1 (Beijing) and SIT53 (T1), similar to findings among pulmonary cases.
CONCLUSIONS:
M. tuberculosis was the main etiological agent of TBLN in Maputo. M. tuberculosis genotypes were similar to the ones causing pulmonary TB, suggesting that in Maputo, cases of TBLN arise from the same source as pulmonary TB, rather than from an external zoonotic source. Further research is needed on other forms of extrapulmonary TB and in rural areas where there is high prevalence of bovine TB in cattle, to evaluate the risk of transmission of M. bovis from cattle to humans.Swedish International Development Cooperation Agency / Department for Research Cooperation (Sida/SAREC) through Eduardo Mondlane University and Karolinska Institutet Research and Training (KIRT) collaboratio
Effect of combination of thalidomide and sulfasalazine in experimentally induced inflammatory bowel disease in rats
672-678Thalidomide provided significant protection against tri nitro benzene
sulfonic acid induced colitis. Combination therapy also reduced colonic
inflammation and all the biochemical parameters (myeloperoxidase
assay, malondialdehyde assay and tumor necrosis factor- ,
estimation) were
significant as compared to control as well as thalidomide alone treated group.
Combination therapy showed additive effect of thalidomide which restored lipid
peroxidation as well as reduced myeloperoxidase and TNF- towards the normal
levels. Morphological and histological scores were significantly reduced in
combination groups. In experimental model of colitis, oral administration of
thalidomide (150 mg/kg) alone as well as its combination with sulfasalazine
(360 mg/kg) significantly reduced the colonic inflammation. The results
indicate the additive effect of thalidomide with sulfasalazine in rat colitis
model which requires further confirmation in human studies